liver cancer

  •  
  •  

    How Would a Northwestern Professor Manage His Own Liver Cancer?

    With: Al B. Benson III, MD, FACP, FACCC, FASCO

    When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks liver cancer expert Al B. Benson III, MD, FACP, FACCC, FASCO, how he would handle his own hypothetical case of liver cancer. Dr. Benson is Professor of Medicine and Associate Director for Cooperative Groups at the Robert H.… Read more »

  •   George Lundberg, MD

    PDF from the National Comprehensive Cancer Network curated by Contributing Editor George Lundberg, MD, who notes: 

    The National Comprehensive Cancer Network (NCCN) has issued a 2020 edition of its Guidelines for Patients about Liver Cancer.

    .

    Go to full document published by the NCCN.

  •   George Lundberg, MD

    Article from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes: 

    In a clinical trial, a combination of the drugs atezolizumab and bevacizumab improved both progression-free survival and overall survival in advanced hepatocarcinoma (the most common form of liver cancer), with fewer adverse effects. These findings were reported in the New England Journal of Medicine.

    Go to full article published by The ASCO Post.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from Medical Xpress curated by Editor in Chief George Lundberg, MD, who notes: 

    Association is not causation. Yet, when the numbers are very high indeed, and the differences stark,  one had best take them seriously. People in the U.K. who drink coffee are half as likely to develop liver cancer, all known confounders considered.

    Go to full article published by Medical Xpress.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from Medscape curated by Editor in Chief George Lundberg, MD, who notes: 

    Always a profoundly difficult cancer to treat, liver cancer rates are greatly increasing, tripling in 20 years in the U.K. Prevention is an urgent need.

    Go to full article published by Medscape.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Although generally not well recognized in the U.S., radiofrequency ablation (RFA) therapy can be highly effective in managing localized smaller lever cancers. Learn more about this treatment approach from the University of Pittsburgh Medical Center.

    .

  •   George Lundberg, MD

    Article from the Journal of Clinical Oncology, selected by Editor in Chief George Lundberg, MD, who notes:

    A hospital chaplain describes a nearly 30 year experience about the importance of engaged hope as he copes with his advanced liver cancer.

    Go to full article published by the Journal of Clinical Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD, who notes:

    Primary liver cell cancer is one of the most common causes of cancer deaths throughout the world. Usually arising in cirrhotic livers, its treatment modalities are many and varied. Cures are elusive except for liver transplantation, but many therapy modalities can sustain prolonged survival. This overview from Medscape provides useful information about the disease.

    .